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Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e55 31intakes of fruits, vegetables, whole-grains, dairy and dairy components, cal-
cium, vitamin D, whey protein, as well as monounsaturated and n-3 fatty
acids.
Conclusions: There was a paucity of information on potential beneﬁts of
traditional dietary patterns from the Asia-Paciﬁc region. Future research
based onwell-designed RCTs or prospective trials could extend the value of
such dietary patterns to other regions of the world.
Funding source(s): N/A.
EFFICACY OF THE PALAEOLITHIC DIET IN HEALTHY FEMALE SUBJECTS
ON CARDIOVASCULAR, METABOLIC AND ANTHROPOMETRIC
OUTCOMES
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Background/Aims: To compare the efﬁcacy of the palaeolithic diet and the
AGHE in terms of metabolic and cardiovascular risk factors and body
composition over a 4-week dietary intervention.
Methods: Thirty nine healthywomen (mean ± SD age 47± 13 y and BMI 27
± 4 kg/m2), were randomised to an ad libitum palaeolithic (n¼ 22) or AGHE
(n ¼ 17) diet for 4 weeks. A 3-day weighed food record (WFR), and blood
and urine samples were collected pre- and post-intervention. Within and
between group analyses were performed using paired t-tests or Mann-
Whitney and independent t-tests, respectively.
Results: Weight loss occurred in both groups, with signiﬁcantly greater loss
(-3.2±1kg vs. -1.2±1kg,p<0.001) and reduction inwaist circumference (3.3
±2cmvs.1.5±2cm,p<0.05) in thepalaeolithic group.A7-9%meanreduction
in total and LDL-cholesterol was observed in both groups with no difference
between groups. Red cell folate (980± 300 vs. 751± 149nmol/L, p< 0.05) and
plasma b-carotene (2.41 ± 2 vs. 1.62 ± 1 mmol/L, p < 0.05) were signiﬁcantly
higher in the palaeolithic group, indicative of the increased fruit and vegetable
consumption. There were no changes in a-carotene or lycopene, or in blood
pressure, fasting insulin, glucose or C-reactive protein in either group.
Conclusions: The palaeolithic diet induced favourable changes in body
composition over a short-term intervention period. The efﬁcacy of the diet
was comparable to other dietary patterns that reduce cardiovascular risk
factors, however further studies are required to assess longer term health
impacts and feasibility of the palaeolithic diet.
Funding source(s): N/A.
ASSOCIATION BETWEEN N-3 PUFA AND BLOOD LIPID PROFILE IN
OLDER AUSTRALIANS
J. Drever 1,2, M. Veysey 3, M. Lucock 4, S. Niblett 3, K. King 3, L. MacDonald-
Wicks 1,2, M.L. Garg 2. 1 School of Health Sciences, University of Newcastle,
NSW, Australia; 2Nutraceuticals Research Group, School of Biomedical
Sciences & Pharmacy, University of Newcastle, NSW, Australia; 3 School of
Medicine & Public Health, University of Newcastle, NSW, Australia; 4 School
Environmental & Life Sciences, University of Newcastle, NSW, Australia
E-mail: Jessica.Drever@uon.edu.au (J. Drever)
Background/Aims: Dietary supplementationwith n-3PUFA has been shown
to retard atherogenic process, partly via improvements in lipoprotein proﬁle.
The objective of this studywas to evaluate any association between n-3PUFA
status and blood lipid levels in a group of older Australians.
Methods: Men (n ¼ 271) and women (n ¼ 349) aged 65-95 years living in
the Central Coast Region of NSW were recruited. Fasting blood samples
were analysed for total cholesterol (TC), TAG, HDL- and LDL-cholesterol. n-
3PUFA status (%EPA plus %DHA) was determined from the fatty acid
composition of erythrocyte membranes analysed by GC.
Results: n-3PUFA statuswas positively associatedwith plasma TC (r¼ 0.082,
p < 0.05), LDL-cholesterol (r ¼ 0.088, p < 0.05) and HDL-cholesterol (r ¼
0.163, p < 0.001), and negatively correlated with plasma TAG (r ¼ -0.217, p <
0.001) levels. The association between n-3PUFA status and plasma TAG was
stronger in females (r ¼ -0.279, p < 0.001) than males (r ¼ -0.141, p < 0.05)
and the association between n-3PUFA status and HDL-cholesterol was
evident in females only (r ¼ 0.177, p < 0.001). The relationship between n-
3PUFA status and TC or LDL-cholesterol levels was not signiﬁcant whenparticipants were stratiﬁed on gender. However, the correlation coefﬁcient
was larger and approached signiﬁcance in the female group.
Conclusions: In this study n-3PUFA status was associated with an anti-
atherogenic blood lipid proﬁle in an older, high risk population in a sex-
dependent manner. These ﬁndings support the development and imple-
mentation of dietary strategies designed to reduce the risk of cardiovas-
cular disease by improving n-3PUFA status.
Funding source(s): ARC.
N-3 PUFA STATUS IS INVERSELY ASSOCIATED WITH TYPE 2 DIABETES
MELLITUS IN OLDER AUSTRALIANS
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Background/Aims: The association between n-3PUFA status and risk of
T2DM remains unclear. We have recently demonstrated a negative asso-
ciation between erythrocyte n-3PUFA levels and insulin resistance in obese
children. This study was to determine whether n-3PUFA status is associ-
ated with T2DM in high risk older Australians.
Methods: A cross-sectional sample of older adults aged 65-95 years (n ¼
620) from the Central Coast Region, NSWwere recruited. Diabetic statuswas
determined according toWorld Health Organisation criteria. n-3PUFA status
(%EPA plus %DHA) was determined by analysing the fatty acid composition
of erythrocyte membranes by GC. Fasting blood sugar (BGL), insulin and
HbA1c levels were measured by a commercial pathology service.
Results: Following application of exclusion criteria, 96 T2DM (females 42.7%;
mean±SDage76.6±6.0years) and512non-T2DM(females58.6%; age77.8±
7.1 years) participants were included in the analysis. Erythrocyte n-3PUFA
levelswere signiﬁcantly lower inT2DMthannon-T2DMsubjects (8.03±2.0%
vs. 8.57 ± 2.3%; p¼ 0.03).When participants were stratiﬁed by BMI, weight-
dependentdifferenceswere evidentwithoverweight/obese ( 27kg/m2)but
not healthy/lowweight (< 27 kg/m2) subjects showing a negative correlation
between n-3PUFA status and T2DM (Goodman-Kruskal’s g ¼ -0.267; p <
0.01). An inverse relationship betweenn-3PUFA status andboth fasting BSL (r
¼ -0.115; p ¼ 0.02) and HbA1c (r ¼ -0.115; p ¼ 0.03) was also detected in
overweight/obese but not healthy/low weight participants. No association
was found between n-3PUFA status and fasting insulin levels.
Conclusions: This is the ﬁrst study to demonstrate a weight-dependent in-
verse relationshipbetween long-termn-3PUFA status andT2D inolderadults.
Funding source(s): ARC.
REPETITIVE GUT CHALLENGE REDUCES GASTRO-INTESTINAL
SYMPTOMS AND MALABSORPTION OF CARBOHYDRATES DURING
EXERTIONAL STRESS
A. Miall 1, A. Khoo 1, C. Rauch 1, P. Gibson 2, R.J.S. Costa 1. 1Department of
Nutrition & Dietetics, Monash University, Melbourne, VIC, Australia;
2Department of Gastroenterology - The Alfred Hospital, Melbourne, VIC,
Australia
E-mail: ricardo.costa@monash.edu (R.J.S. Costa)
Background/Aims: The study aimed to determine if commonly reported
and debilitating gastrointestinal symptoms (GIS) and carbohydrate
malabsorption during exertional stress is altered by daily gut-challenge
over two weeks.
Methods: Healthy endurance trained participants performed an initial
gut-challenge trial (GC1) comprising 2 hours of running at 60% VO2max
whilst consuming 30 g carbohydrates (2:1 glucose-fructose, 10% weight:-
volume) every 20 mins, followed by a 1 hour time trial. GIS were moni-
tored every 10 mins during exercise using a 10 cm rating scale. Breath
samples were collected every hour during exercise and recovery, and
analysed via a Breathtracker Digital Microlyzer. After 10-days’ gut training
protocol comprising of 1 hour of running at 60% VO2max whilst consuming
30 g carbohydrate (2:1 glucose-fructose, 10% weight:volume) every 20
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lysed by repeated measures ANOVA with post hoc and non-parametric
equivalents (Friedman) where appropriate.
Results: Overall GIS were lower in GC2 compared to GC1 (accumulated
rating: 86 cm vs. 508 cm; p < 0.05). Commonly reported GIS in GC1
included: belching, bloating, urge to vomit, stomach and intestinal pain,
ﬂatulence, urge to defecate and nausea; all subsiding in GC2. Taste fatigue
and tolerance to food-ﬂuid improved in GC2 compared to GC1 (p < 0.05).
Breath hydrogen was lower in GC2 compared to GC1 (AUC: 1500 ± 589
ppm/300 min vs. 2580 ± 704 ppm/300 min; p < 0.01), with no signiﬁcant
change in breath methane observed.
Conclusions: Findings suggest that 10-days’ of gut-challenge improves
GIS, food-ﬂuid intake ability and absorption during exertional stress. Ul-
timately, this may have substantial impact on exercise performance.
Funding source(s): N/A.
DIETARY SUPPLEMENTATION WITH FRUCTOSE OR GLUCOSE DOES NOT
INFLUENCE BLOOD LIPIDS AND CdREACTIVE PROTEIN IN HEALTHY
SUBJECTS
F. Jameel 1,2, L.G. Wood 2, M.L. Garg 1,2. 1Nutraceuticals Research Group
University of Newcastle, NSW, Australia; 2 School of Biomedical Sciences &
Pharmacy, University of Newcastle, NSW, Australia
E-mail: Faizan.Jameel@newcastle.edu.au (F. Jameel)
Background/Aims: The mechanisms by which consumption of fructose
rich diets may be linked with elevated risk of developing obesity and
related chronic diseases remain debatable. Fructose-induced hyper-
lipidaemia and inﬂammation have been thought to mediate the adverse
health effects of fructose. This study aimed to investigate the effects of
dietary supplementation with fructose or glucose on blood lipids and low
grade inﬂammation in healthy subjects.
Methods: This was a two-arm, parallel-design, randomised dietary inter-
vention trial. Participants (n ¼ 24) were asked to supplement their usual
diets with 50 g of either fructose or glucose per day for a period of 4 weeks.
Blood samples were collected at baseline and post intervention for the
analysis of blood lipids, glucose, insulin and high sensitivity C-reactive
protein (hs-CRP). An independent-sample t-test was conducted to
compare the effects of fructose and glucose supplementation.
Results: Following dietary supplementationwith fructose or glucose there
was no signiﬁcant difference in fasting blood insulin, glucose, total
cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, total/HDL
cholesterol ratio and hs-CRP levels (all p > 0.05). The change in blood
glucose, insulin, hs-CRP and lipid levels from baseline to post-intervention
with fructose versus glucose were also similar.
Conclusions: Type of sugar (fructose or glucose) consumed does not in-
ﬂuence blood lipid proﬁle, glycaemic indices and low grade inﬂammation
in healthy individuals.
Funding source(s): Hunter Medical Research Institute.
EFFECT OF NUTRITIONAL SUPPLEMENT THERAPIES IN THE
PREVENTION OF ALZHEIMER’S DISEASE IN A TRANSGENIC MOUSE
MODEL
M.J. Sharman 1, D. Ong 2, G. Verdile 3, G. Munch 4, M. Wenk 5, B.
Halliwell 5, R.N. Martins 2. 1 School of Health Sciences, University of
Tasmania, Australia; 2 School of Medical Sciences, Edith Cowan University,
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Background/Aims: The aim of this study was to examine the efﬁcacy of
diets containing (-)-epigallocatechin-3-gallate (EGCG), curcumin (Curc),
DHA and a-lipoic acid (ALA) on reducing cognitive deﬁcits and brain beta-
amyloid (Ab) levels in a transgenic Alzheimer’s disease (AD) mouse model.
Methods: Sixty mice (age six months) were randomly assigned to one of
six nutritional supplement groups (Control, Curc, Curc+EGCG+ALA,
Curc+DHA+ALA, EGCG+DHA+ALA, Curc+EGCG+DHA+ALA) for 12 months.
At 18 months of age, the cognitive effects of the nutritional supplements
were evaluated behaviourally using the cued and contextual fearavoidance test. A commercially available assay was used for the detection
andmeasurement of Ab levels in the brain. Difference between groups was
tested using one-way ANOVA.
Results: All nutritional supplement groups had lower frontal cortex Ab42
levels compared to Controls (p < 0.05). Only the DHA+EGCG+ALA group
had reduced frontal cortex Ab40 levels compared to Controls (p < 0.05). No
differences were observed in cerebellum Ab42 levels, although the Cur-
c+EGCG+ALA and DHA+EGCG+ALA groups did have lower cerebellum Ab40
levels compared to Controls (p < 0.05). All nutritional supplement com-
bination groups had signiﬁcant increases in time spent freezing in the
context, altered context and auditory cue conditions in the cued and
contextual fear avoidance testing compared to Controls (p < 0.05).
Conclusions: The combination nutritional supplements in this study were
effective at lowering brain Ab42 levels and improving cognition. However
there does not appear to be additional beneﬁts from combinations of these
nutritional components over a single nutritional supplement of Curc.
Funding source(s): NHMRC.
OMEGA-3 INDEX AND LIVER FAT: AN UNEXPECTED RELATIONSHIP
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Caterson 4, J. George 5, N.A. Johnson 1. 1Discipline of Exercise & Sport
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Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is an inde-
pendent predictor of CVD. n-3 PUFA supplementation has been shown to
improve NAFLD. This study aimed to examine the relationship of the
Omega-3 Index (O3I; a biomarker of n-3 status) with liver fat (intrahepatic
lipid concentration; IHL%).
Methods: Eighty overweight/obese, healthy, non-smoker adults (56
males) undertook MRI and proton magnetic resonance spectroscopy (1H-
MRS) to measure abdominal adiposity and IHL% within seven days of
undergoing anthropometric measurements and providing a blood sample
for biochemical and erythrocyte lipid analysis. Correlations with liver fat
were examined and linear regression for the prediction of IHL% was per-
formed. Mean ± SEM are reported.
Results: O3I was high in participants with (9.0 ± 0.3%) and without (8.4 ±
0.3%) NAFLD, and was positively correlated with IHL% (r ¼ 0.255, p ¼ 0.029),
although further analysis revealed this was stronger and statistically signif-
icant for males (r ¼ 0.425, p¼ 0.001) and not females (r¼ 0.020, p¼ 0.925).
Linear regression showed that O3I and erythrocyte n-6:n-3 ratio together
signiﬁcantlyexplained28%of thevariance in IHL% (p¼ 0.046). The additionof
BMI, waist and age raised the predictive power to 58% (p < 0.001). Further
addition of biochemical markers (TAG, HDL, high-sensitive C-reactive pro-
tein) increased the total variance explained by the model to 66%.
Conclusions: In overweight/obese adults, O3I was unexpectedly positively
associated with IHL%, however gender differences apparent in this cohort
warrant further research. In overweight obese adults, simple anthropo-
metric and demographic measures may be of equal or greater utility than
erythrocyte PUFA analysis in identifying those at increased risk of NAFLD.
Funding source(s): Blackmores; Diabetes Australia.
EVALUATING AN INNOVATIVE FOODSERVICE APPROACH TO
MALNUTRITION IN HEALTHCARE
J. Collins 1, C. Huggins 1, J. Porter 1,2, H. Truby 1. 1Nutrition and Dietetics
Department, Monash University, Australia; 2Dietetics Department, Eastern
Health, VIC, Australia
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Background/Aims: Malnutrition in healthcare facilities remains an
ongoing challenge. Opportunities exist to develop the foodservice system
and engage this workforce to improve patient outcomes. The aim was to
determine the effect of changing the foodservice system on anthropom-
etry and patients’ satisfaction with the foodservice.
Methods: The intervention consisted of a high-energy hospital menu and
greater foodservice staff-patient interaction. Patients in subacute care
